María del Socorro España Lomelí, the executive director of Mexico's National Association of Manufacturers of Medicines (ANAFAM), speaks to PharmaBoardroom about ANAFAM's evolving relationship with the Mexican government and the changes in the country's procurement law, which gave rise to widespread procurement issues. She also discusses ANAFAM member companies' internationalisation ambitions and foreign companies' interest in investing in Mexico.
The issue of health is simply not a priority for the government. This is evident through the way they minimise many important aspects of the process that allows medicines to reach patients.
